Evaluation of the effect of vitamin C on flu-like syndrome in multiple sclerosis patients receiving beta-interfero
Phase 3
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20211122053145N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients who have Multiple Sclerosis according to McDonald criteria.
Beta-interferon is prescribed for them for the first time.
Exclusion Criteria
Patients who don't want to participate in this project.
Patients that take vitamin C themselves.
Patients who receive drugs other than beta-interferon for treatment of Multiple Sclerosis.
Patients who have other autoimmune diseases or underlying diseases except Multiple Sclerosis.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method